Literature DB >> 11012585

Management of nail psoriasis.

D de Berker1.   

Abstract

Nail psoriasis is often difficult to cure, but may respond to a range of different approaches used alone or together. As with treatment of psoriasis affecting skin, relapse is common and therapies may need to be maintained or repeated. The exact benefits of many of these treatments are not well documented in the literature. Basic nail care is important and topical therapies represent the main modality of treatment for the majority of cases. In severe nail disease, where there is a hypertrophic element, injection therapy with triamcinolone may be helpful. PUVA and other forms of radiation may be of benefit, but as with systemic therapy, they are usually useful in the context of treatment of psoriasis elsewhere on the body.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012585     DOI: 10.1046/j.1365-2230.2000.00663.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

1.  Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study.

Authors:  María Denise Takahashi; Edgardo Néstor Chouela; Gladys Leon Dorantes; Ana Maria Roselino; Jesùs Santamaria; Miguel Angel Allevato; Tania Cestari; Maria Eugenia Manzanera de Aillaud; Fernando Miguel Stengel; Daiana Licu
Journal:  Arch Drug Inf       Date:  2010-03

2.  Nail psoriasis: clinical presentation and best practice recommendations.

Authors:  Felicity Edwards; David de Berker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

3.  Dermoscopic Features of Nail Psoriasis: An Observational, Analytical Study.

Authors:  Ankita Chauhan; Archana Singal; Chander Grover; Sonal Sharma
Journal:  Skin Appendage Disord       Date:  2020-06-11

4.  Efficacy of Systemic Treatments of Nail Psoriasis: A Systemic Literature Review and Meta-Analysis.

Authors:  Xuan Zhang; Bingbing Xie; Yanling He
Journal:  Front Med (Lausanne)       Date:  2021-02-10

5.  Toenail Psoriasis during Ustekinumab Therapy: Results and Limitations.

Authors:  Seungkeol Yang; Bo Ri Kim; Minsu Kim; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2021-03-08       Impact factor: 1.444

Review 6.  Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.

Authors:  Trinh Hermanns-Lê; Enzo Berardesca; Gérald E Piérard; Marianne Lesuisse; Claudine Piérard-Franchimont
Journal:  J Biomed Biotechnol       Date:  2012-08-13

Review 7.  Nail psoriasis: the journey so far.

Authors:  Alka Dogra; Amanjot Kaur Arora
Journal:  Indian J Dermatol       Date:  2014-07       Impact factor: 1.494

Review 8.  Current trends in needle-free jet injection: an update.

Authors:  Daniel Barolet; Antranik Benohanian
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-05-01

9.  The prevalence and etiological factors of onychomycosis in psoriatic patients.

Authors:  Alicja Romaszkiewicz; Barbara Bykowska; Monika Zabłotna; Michał Sobjanek; Martyna Sławińska; Roman J Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.